- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 3.2 Form of Certificate of Incorporation of the Combined Entity (Attached to the Proxy Statement/prospectus Which Forms a Part of This Registration Statement As Annex B)
- 3.4 Form of Bylaws of the Combined Entity (Attached to the Proxy Statement/prospectus Which Forms a Part of This Registration Statement As Annex C)
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Larkspur Health Acquisition Corp.
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Zyversa Therapeutics, Inc.
- 99.6 Consent of Cassel Salpeter & Co., LLC (Attached to the Proxy Statement/prospectus Which Forms a Part of This Registration Statement As Annex G)
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
- 15 Nov 22 EFFECT Notice of effectiveness
- 14 Nov 22 424B3 Prospectus supplement
- 3 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 20 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
-
12 Aug 22 S-4 Registration of securities issued in business combination transactions
- 3 Nov 22 Registration of securities issued in business combination transactions (amended)
- 20 Oct 22 Registration of securities issued in business combination transactions (amended)
- 27 Sep 22 Registration of securities issued in business combination transactions (amended)
- 12 Aug 22 Registration of securities issued in business combination transactions
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Larkspur Health Acquisition Corp. (the “Company”) on Form S-4 of our report dated April 14, 2022, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of Larkspur Health Acquisition Corp. as of December 31, 2021 and for the period from March 17, 2021 (inception) through December 31, 2021, which report appears in the Proxy Statement/Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Proxy Statement/Prospectus.
/s/ Marcum llp
Marcum llp
New York, NY
August 12, 2022